Skip to main content
Skip main navigationClose Drawer MenuOpen Drawer Menu

Cardiac Sympathetic Imaging With mIBG in Heart FailureFree Access

State-of-the-Art Paper

J Am Coll Cardiol Img, 3 (1) 92–100

Cardiac sympathetic imaging with meta-iodobenzylguanidine (mIBG) is a noninvasive tool to risk stratify patients with heart failure (HF). In patients with ischemic and nonischemic cardiomyopathy, cardiac mIBG activity is a very powerful predictor of survival. Cardiac sympathetic imaging can help in understanding how sympathetic overactivity exerts its deleterious actions, which may result in better therapy and outcome for patients with HF.